295 related articles for article (PubMed ID: 2506219)
1. Delayed occurrence of an LH surge after HCG administration during ovarian stimulation with gonadotrophins: effect of LHRH treatment.
Rojas FJ; Moretti-Rojas I; Balmaceda JP; Asch RH
Hum Reprod; 1989 Aug; 4(6):643-6. PubMed ID: 2506219
[TBL] [Abstract][Full Text] [Related]
2. Assessment of serum luteinizing hormone during ovarian stimulation with gonadotrophins.
Rojas FJ; Moretti-Rojas I; Balmaceda JP; Asch RH
Hum Reprod; 1988 Feb; 3(2):207-11. PubMed ID: 3128573
[TBL] [Abstract][Full Text] [Related]
3. Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization.
Droesch K; Muasher SJ; Brzyski RG; Jones GS; Simonetti S; Liu HC; Rosenwaks Z
Fertil Steril; 1989 Feb; 51(2):292-7. PubMed ID: 2492234
[TBL] [Abstract][Full Text] [Related]
4. Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells.
Minaretzis D; Alper MM; Oskowitz SP; Lobel SM; Mortola JF; Pavlou SN
Am J Obstet Gynecol; 1995 May; 172(5):1518-25. PubMed ID: 7755066
[TBL] [Abstract][Full Text] [Related]
5. Spontaneous luteinizing hormone surges can be reliably prevented by the timely administration of a gonadotrophin releasing hormone antagonist (Nal-Glu) during the late follicular phase.
Frydman R; Cornel C; de Ziegler D; Taieb J; Spitz IM; Bouchard P
Hum Reprod; 1992 Aug; 7(7):930-3. PubMed ID: 1430131
[TBL] [Abstract][Full Text] [Related]
6. Variations of luteinizing hormone serum concentrations after exogenous human chorionic gonadotropin administration during ovarian hyperstimulation.
Demoulin A; Dubois M; Gerday C; Gillain D; Lambotte R; Franchimont P
Fertil Steril; 1991 Apr; 55(4):797-804. PubMed ID: 1901284
[TBL] [Abstract][Full Text] [Related]
7. Subcutaneous low dose leuprolide acetate depot versus leuprolide acetate for women undergoing ovarian stimulation for in-vitro fertilization.
Tsai HD; Chen CM; Lo HY; Chang CC
Hum Reprod; 1995 Nov; 10(11):2909-12. PubMed ID: 8747042
[TBL] [Abstract][Full Text] [Related]
8. [A study of the controlled ovarian hyperstimulation using GnRH agonist and pure FSH in in vitro fertilization-embryo transfer and gamete intrafallopian transfer program].
Usui A
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1431-8. PubMed ID: 2511261
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of gonadotrophin-releasing hormone agonists administered as desensitizing or flare protocols on hormonal function in the luteal phase of hyperstimulated cycles.
Norman RJ; Warnes GM; Wang X; Kirby CA; Matthews CD
Hum Reprod; 1991 Feb; 6(2):206-13. PubMed ID: 1905309
[TBL] [Abstract][Full Text] [Related]
10. An analysis of the LH profile in relation to ovarian stimulation regimes and embryo transfer rates in an in vitro fertilisation programme.
Umapathysivam K; Jones WR; Meffin E
Clin Reprod Fertil; 1986 Jun; 4(3):227-32. PubMed ID: 3091237
[TBL] [Abstract][Full Text] [Related]
11. Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization.
Gonen Y; Balakier H; Powell W; Casper RF
J Clin Endocrinol Metab; 1990 Oct; 71(4):918-22. PubMed ID: 2119392
[TBL] [Abstract][Full Text] [Related]
12. In vitro fertilization: diurnal and seasonal variation in luteinizing hormone surge onset and pregnancy rates.
Casper RF; Erskine HJ; Armstrong DT; Brown SE; Daniel SA; Graves GR; Yuzpe AA
Fertil Steril; 1988 Apr; 49(4):644-8. PubMed ID: 3127247
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of short-term gonadotrophin-releasing hormone agonists versus human chorionic gonadotrophin to enable oocyte release in gonadotrophin stimulated cycles.
Check JH; Nazari A; Barnea ER; Weiss W; Vetter BH
Hum Reprod; 1993 Apr; 8(4):568-71. PubMed ID: 8501187
[TBL] [Abstract][Full Text] [Related]
14. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
[TBL] [Abstract][Full Text] [Related]
15. Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation.
Diedrich K; Diedrich C; Santos E; Zoll C; al-Hasani S; Reissmann T; Krebs D; Klingmüller D
Hum Reprod; 1994 May; 9(5):788-91. PubMed ID: 7929723
[TBL] [Abstract][Full Text] [Related]
16. Comparison of LH concentrations in the early and mid-luteal phase in IVF cycles after treatment with HMG alone or in association with the GnRH antagonist Cetrorelix.
Tavaniotou A; Albano C; Smitz J; Devroey P
Hum Reprod; 2001 Apr; 16(4):663-7. PubMed ID: 11278214
[TBL] [Abstract][Full Text] [Related]
17. Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response.
Chang FE; Beall SA; Cox JM; Richter KS; DeCherney AH; Levy MJ
Fertil Steril; 2016 Oct; 106(5):1093-1100.e3. PubMed ID: 27341988
[TBL] [Abstract][Full Text] [Related]
18. Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing.
Ibañez L; Hall JE; Potau N; Carrascosa A; Prat N; Taylor AE
J Clin Endocrinol Metab; 1996 Nov; 81(11):4103-7. PubMed ID: 8923867
[TBL] [Abstract][Full Text] [Related]
19. Relative bioactivity of endogenous luteinizing hormone during superovulation therapy for in vitro fertilization in normal-cycling women.
Abuzeid MI; Hodges JK; Harlow CR; Hull MG
J Assist Reprod Genet; 1996 Sep; 13(8):629-34. PubMed ID: 8897122
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of a combination administration of gonadotropin-releasing hormone agonist and gonadotropins for controlled ovarian hyperstimulation in IVF program.
Chang YS; Kim SH; Shin CJ; Kim JG; Moon SY; Lee JY
Asia Oceania J Obstet Gynaecol; 1990 Dec; 16(4):337-45. PubMed ID: 2129188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
